About the Study

Volunteer for a clinical study ARISE 201 to support primary hypersomnia research

We are evaluating an investigational drug to improve excessive daytime sleepiness and other symptoms experienced by people with Idiopathic Hypersomnia and Narcolepsy without cataplexy.

What is the purpose of the study?

This is a clinical study to evaluate the safety and tolerability of an investigational drug and its effect on daytime sleepiness, tiredness, fatigue and function in people with Idiopathic Hypersomnia or Narcolepsy without cataplexy.

What are the criteria for participation?

  • Male or female with Idiopathic Hypersomnia or Narcolepsy without cataplexy
  • 18 years and older
  • In good general health
  • Other criteria to be evaluated by the study site staff

What will happen during the study?

  • All subjects enrolled will receive both the study drug, and a placebo, at different times during the study.
  • All subjects will go through two washout periods when no study drug is administered.
  • There will be 6 clinic visits over a 8 week period.
  • A full physical examination and a review of health status will be conducted at all study visits
  • Tests that measure daytime sleepiness, tiredness, fatigue and function will be taken at each clinic visit
  • Subjects will be asked to complete daily sleep diaries throughout the study

Where is the study taking place?

This study is being conducted at clinical study sites across the United States

Who to contact?

Fill out the “See If You Qualify” questionnaire and a study representative will follow up.